Parallax Volatility Advisers, L.P. Gilead Sciences, Inc. Transaction History

Parallax Volatility Advisers, L.P.

$53.5 Billion
Q3 2024

A detailed history of Parallax Volatility Advisers, L.P. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 54,955 shares of GILD stock, worth $5.06 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

54,955

Previous 166,613 67.02%

Holding current value

$5.06 Million

Previous $11.4 Million 59.71%

% of portfolio

0.01%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $7.44 Million - $9.38 Million	-111,658 Reduced 67.02%	54,955 $4.61 Million
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $10.5 Million - $12.1 Million	166,613 New	166,613 $11.4 Million
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $2.22 Million - $2.53 Million	-29,203 Reduced 99.08%	270 $20,000
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $2.26 Million - $2.58 Million	29,293 Added 16273.89%	29,473 $2.45 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $798,942 - $1.15 Million	-12,820 Reduced 98.62%	180 $15,000
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $313,775 - $358,412	-5,270 Reduced 28.85%	13,000 $802,000
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $1.43 Million - $1.61 Million	-24,696 Reduced 57.48%	18,270 $1.13 Million
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $7.79 Million - $8.85 Million	-120,132 Reduced 73.66%	42,966 $3.12 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $8.33 Million - $8.99 Million	-123,037 Reduced 43.0%	163,098 $11.4 Million
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $5.6 Million - $6.12 Million	88,256 Added 44.6%	286,135 $19.7 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $11.3 Million - $12.9 Million	-188,965 Reduced 48.85%	197,879 $12.8 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $20.2 Million - $23 Million	-356,219 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $21.9 Million - $25 Million	386,844 New	386,844 $22.5 Million
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $19 Million - $23.9 Million	305,651 Added 604.44%	356,219 $22.5 Million
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $2.83 Million - $3.28 Million	39,078 Added 340.1%	50,568 $3.89 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $2.11 Million - $2.7 Million	-33,696 Reduced 74.57%	11,490 $859,000
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $1.39 Million - $1.53 Million	-22,594 Reduced 33.33%	45,186 $2.94 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $2.37 Million - $2.62 Million	37,912 Added 126.93%	67,780 $4.3 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $736,871 - $826,315	11,910 Added 66.32%	29,868 $2.02 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $3.23 Million - $3.62 Million	-51,706 Reduced 74.22%	17,958 $1.17 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $2.7 Million - $3.53 Million	44,664 Added 178.66%	69,664 $4.36 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $5.01 Million - $5.55 Million	-70,337 Reduced 73.78%	25,000 $1.93 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $1.82 Million - $2.14 Million	25,600 Added 36.71%	95,337 $6.83 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $5.03 Million - $5.96 Million	69,737	69,737 $5.65 Million

Others Institutions Holding GILD

# of Institutions

1,917

Shares Held

995M

Call Options Held

10.1M

Put Options Held

9.46M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $115B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.

Account

Parallax Volatility Advisers, L.P. Gilead Sciences, Inc. Transaction History